82 related articles for article (PubMed ID: 17768004)
1. Low dose Zebularine treatment enhances immunogenicity of tumor cells.
Liu H; Xue ZT; Sjögren HO; Salford LG; Widegren B
Cancer Lett; 2007 Nov; 257(1):107-15. PubMed ID: 17768004
[TBL] [Abstract][Full Text] [Related]
2. An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: potential therapeutic use in autoimmune diseases.
Xue ZT; Sjögren HO; Salford LG; Widegren B
Mol Immunol; 2012 Jun; 51(2):101-11. PubMed ID: 22424783
[TBL] [Abstract][Full Text] [Related]
3. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression.
Scott SA; Lakshimikuttysamma A; Sheridan DP; Sanche SE; Geyer CR; DeCoteau JF
Exp Hematol; 2007 Feb; 35(2):263-73. PubMed ID: 17258075
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine.
Dote H; Cerna D; Burgan WE; Carter DJ; Cerra MA; Hollingshead MG; Camphausen K; Tofilon PJ
Clin Cancer Res; 2005 Jun; 11(12):4571-9. PubMed ID: 15958643
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of DNA methylation and reactivation of silenced genes by zebularine.
Cheng JC; Matsen CB; Gonzales FA; Ye W; Greer S; Marquez VE; Jones PA; Selker EU
J Natl Cancer Inst; 2003 Mar; 95(5):399-409. PubMed ID: 12618505
[TBL] [Abstract][Full Text] [Related]
6. Zebularine induces prolonged apoptosis effects via the caspase-3/PARP pathway in head and neck cancer cells.
Napso T; Fares F
Int J Oncol; 2014 Jun; 44(6):1971-9. PubMed ID: 24728469
[TBL] [Abstract][Full Text] [Related]
7. T-cell proliferation is inhibited by the induction of indoleamine 2,3-dioxygenase in spleen-derived dendritic cells in rat.
Xu J; Yao N; Li YD
Chin Med J (Engl); 2011 Oct; 124(19):3154-8. PubMed ID: 22040571
[TBL] [Abstract][Full Text] [Related]
8. DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer.
Chen M; Shabashvili D; Nawab A; Yang SX; Dyer LM; Brown KD; Hollingshead M; Hunter KW; Kaye FJ; Hochwald SN; Marquez VE; Steeg P; Zajac-Kaye M
Mol Cancer Ther; 2012 Feb; 11(2):370-82. PubMed ID: 22203734
[TBL] [Abstract][Full Text] [Related]
9. Zebularine significantly sensitises MEC1 cells to external irradiation and radiopharmaceutical therapy when administered sequentially in vitro.
Bryan JN; Kumar SR; Jia F; Balkin ER; Lewis MR
Cell Biol Int; 2014 Feb; 38(2):187-97. PubMed ID: 24323360
[TBL] [Abstract][Full Text] [Related]
10. Zebularine-induced myeloma cell death is accompanied by decreased c-Myc expression.
Krzeminski P; García-Sanz R; Gutiérrez NC
Cell Oncol (Dordr); 2020 Aug; 43(4):743-750. PubMed ID: 32394351
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model.
Yoshida N; Ino K; Ishida Y; Kajiyama H; Yamamoto E; Shibata K; Terauchi M; Nawa A; Akimoto H; Takikawa O; Isobe K; Kikkawa F
Clin Cancer Res; 2008 Nov; 14(22):7251-9. PubMed ID: 19010841
[TBL] [Abstract][Full Text] [Related]
13. Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy.
Marquez VE; Kelley JA; Agbaria R; Ben-Kasus T; Cheng JC; Yoo CB; Jones PA
Ann N Y Acad Sci; 2005 Nov; 1058():246-54. PubMed ID: 16394141
[TBL] [Abstract][Full Text] [Related]
14. 6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells.
Flesner BK; Kumar SR; Bryan JN
BMC Vet Res; 2014 Dec; 10():290. PubMed ID: 25480665
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs.
Fulkerson CM; Dhawan D; Jones DR; Marquez VE; Jones PA; Wang Z; Wu Q; Klaunig JE; Fourez LM; Bonney PL; Knapp DW
Vet Comp Oncol; 2017 Mar; 15(1):226-236. PubMed ID: 26178438
[TBL] [Abstract][Full Text] [Related]
16. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).
Sarkhosh K; Tredget EE; Karami A; Uludag H; Iwashina T; Kilani RT; Ghahary A
J Cell Biochem; 2003 Sep; 90(1):206-17. PubMed ID: 12938169
[TBL] [Abstract][Full Text] [Related]
17. Zebularine exerts its antiproliferative activity through S phase delay and cell death in human malignant mesothelioma cells.
Takemura Y; Satoh M; Hatanaka K; Kubota S
Biosci Biotechnol Biochem; 2018 Jul; 82(7):1159-1164. PubMed ID: 29685095
[TBL] [Abstract][Full Text] [Related]
18. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
[TBL] [Abstract][Full Text] [Related]
19. Zebularine partially reverses GST methylation in prostate cancer cells and restores sensitivity to the DNA minor groove binder brostallicin.
Sabatino MA; Geroni C; Ganzinelli M; Ceruti R; Broggini M
Epigenetics; 2013 Jun; 8(6):656-65. PubMed ID: 23771052
[TBL] [Abstract][Full Text] [Related]
20. Effect of valproic acid and zebularine on SOCS-1 and SOCS-3 gene expression in colon carcinoma SW48 cell line.
Sanaei M; Kavoosi F; Behjoo H
Exp Oncol; 2020 Sep; 42(3):183-187. PubMed ID: 32996734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
